[News Brief] GSK: Arexvy Linked to Lower RSV-Related Cardiopulmonary Risks
GSK has published findings indicating its respiratory syncytial virus (RSV) vaccine Arexvy was associated with reduced risks of certain severe…
GSK has published findings indicating its respiratory syncytial virus (RSV) vaccine Arexvy was associated with reduced risks of certain severe…
ViiV Healthcare has reported that final data from the LATITUDE phase III trial show its long-acting injectable regimen, Cabenuva (cabotegravir…
Otsuka has stated that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application…
Johnson & Johnson has published an Innovation feature detailing the development of Shockwave Medical’s intravascular lithotripsy (IVL) system, which uses…
The European Commission has approved a 7.2 mg once-weekly maintenance dose of Wegovy® (semaglutide) for adults with obesity across all…
NXP Semiconductors and GE HealthCare announced a collaboration to develop edge artificial intelligence (AI) concepts for acute care settings, showcased…
Intuitive announced at STS 2026 that its latest surgical robotics platform, da Vinci 5, is now available for selected cardiac…
A Media Release from nutraceutical company Bio-gen Extracts highlights a new Australian clinical study which has found that the carotenoids…
MindMaze Therapeutics Holding SA (SIX: MMTX) announced the completion of its business combination with NeuroX Group SA, to form a…
A new generative AI system developed by researchers from the University of Cambridge, University College London and Queen Mary University…